Sinitsyna N.I.

Sinitsyna N.I.

Auto-generated profile, based on publicly available information

Sinitsyna N.I.

Peoples' Friendship University of Russia, Moscow, Russian Federation

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2022 in Drug development & registration
Verified
Journal Article
Open access
PDF file
SAS. A. Abdulrazzak
S. A. Abdulrazzak
AVAlexander Vorobyev
Alexander Vorobyev
NSN. I. Sinitsyna
N. I. Sinitsyna
ISI. V. Sharutin
I. V. Sharutin
OMO. V. Menshova
O. V. Menshova
KSK. M. Sakanyan
K. M. Sakanyan
Разработка таблеток для приема внутрь на основе дигидрокверцетина и оценка их общетоксического действия

19 April 2022 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
SASayed Ahmad A.
Sayed Ahmad A.
AVAlexander Vorobyev
Alexander Vorobyev
SNSinitsyna N.I.
Sinitsyna N.I.
RARimma Abramovich
Rimma Abramovich
OPOlga Georgievna O. G. Potanina
Olga Georgievna O. G. Potanina
The possibility of using arabinogalactan in the preparation of oral tablets based on the natural bioflavonoid dihydroquercetin has been shown. The composition and technology of tablets using the wet granulation method has been developed. The quantitative content of dihydroquercetin in tablets was determined by HPLC. Aim. Development the composition and technology of dihydroquercetin tablets for oral administration using arabinogalactan.

10 April 2022 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
SASayed Ahmad A.
Sayed Ahmad A.
SNSinitsyna N.I.
Sinitsyna N.I.
RARimma Abramovich
Rimma Abramovich
AVAlexander Vorobyev
Alexander Vorobyev
OPOlga Georgievna O. G. Potanina
Olga Georgievna O. G. Potanina
Dihydroquercetin (DHQ) is a bioflavonoid from the flavonol group with a wide spectrum of pharmacological activity. Antioxidant, strengthens the walls of blood vessels. Medicinal product based on dihydroquercetin for topical use. Aim. Development of a dosage form of dihydroquercetin in the form of a gel for topical use and evaluation of its physicochemical properties, general toxic effects and safety. Materials and methods. The gel was obtained on an EKROS PE-8100 laboratory overhead stirrer (EKROS, Russia). The substance of dihydroquercetin of the LLC "Chemistry of Woods" company was used. Dimethyl sulfoxide, glycerin, and polyethylene glycol 400 were used as solvents for the active substance. Gelling agents were used, such as: hydroxyethyl cellulose, carbomer brand Carbopol Ultrez 10, poloxamer 407, polymer compositions of the French company Seppic Sepineo p600 and Sepineo Derm. Benzyl alcohol and sodium benzoate are used as antimicrobial preservatives. Trilon B was used as a stabilizer. Purified water served as a dispersion medium. Aggregate stability of the gels was evaluated according to GOST 29188.3-91 COSMETIC PRODUCTS [1]. Colloidal stability - on the centrifuge of the laboratory brand PE-6906. Thermal stability was determined by thermostating the gel samples in an electric dry-air thermostat of the TS-1/20 SPU brand. Dynamic viscosity was determined on a Brookfield DV3T rotational viscometer [2]. The release of DHQ from the model gel compositions was determined by L. The content of DHQ in the dialysate was determined by HPLC (n=5) [3]. Results and discussion. The solubility of the substance of dihydroquercetin was determined for the implementation of the technological process for the manufacture of a gel based on it with increased bioavailability. Chromatography conditions were selected for the determination of dihydroquercetin in the gel by HPLC-UV. The safety and absence of a local irritant effect were established with the use of 2% dihydroquercetin gel. Conclusion. As a result of the research, the composition and technology of a 2% dihydroquercetin gel for topical use have been developed. A technological scheme for obtaining the gel has been developed. The results of the toxicity study of 2% dihydroquercetin gel showed that the gel is non-toxic and safe drug.